464490 — QuadMedicine Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩103bn
- KR₩86bn
- KR₩11bn
Annual cashflow statement for QuadMedicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -9,759 | -4,968 | -6,931 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 1,443 | 823 | 516 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 8,005 | 2,065 | -1,428 |
| Change in Accounts Receivable | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 1,760 | 1,072 | -4,547 |
| Capital Expenditures | -11,912 | -3,505 | -2,415 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 4,626 | 56.2 | -1,898 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -7,286 | -3,449 | -4,313 |
| Financing Cash Flow Items | 196 | 74 | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 6,262 | 8,061 | 25,431 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 757 | 5,814 | 16,244 |